Anew Medical Says It Will Pursue Neurological Approach To Treating Weight Loss And Eating Disorders Through Melanocortin Receptor Binding Peptides
新醫療公司表示,將通過黑素皮質素受體結合肽追求神經學方法治療減重和飲食失調。
Anew Medical Says It Will Pursue Neurological Approach To Treating Weight Loss And Eating Disorders Through Melanocortin Receptor Binding Peptides
新醫療公司表示,將通過黑素皮質素受體結合肽追求神經學方法治療減重和飲食失調。
使用瀏覽器的分享功能,分享給你的好友吧